SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Donders Adrianus

(Last) (First) (Middle)
2800 PATTON ROAD

(Street)
ST. PAUL MN 55113

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EnteroMedics Inc [ ETRM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr VP of Research & Adv Dev
3. Date of Earliest Transaction (Month/Day/Year)
03/09/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
No securities are held 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $2.76 (1) 04/11/2015 Common Stock 14,652 14,652 D
Stock Option (right to buy) $2.76 (1) 04/27/2015 Common Stock 3,663 3,663 D
Stock Option (right to buy) $2.76 (1) 04/20/2016 Common Stock 5,769 5,769 D
Stock Option (right to buy) $1.9 10/29/2010(2) 10/29/2017 Common Stock 7,268 7,268 D
Stock Option (right to buy) $1.9 10/29/2010(2) 10/29/2017 Common Stock 5,925 5,925 D
Stock Option (right to buy) $1.9 10/29/2010(2) 10/29/2017 Common Stock 1,337 1,337 D
Stock Option (right to buy) $1.9 10/29/2010(2) 10/29/2017 Common Stock 10,835 10,835 D
Stock Option (right to buy) $1.9 10/29/2010(2) 10/29/2017 Common Stock 5,847 5,847 D
Stock Option (right to buy) $3.78 (1) 11/18/2019 Common Stock 11,666 11,666 D
Stock Option (right to buy) $2.58 03/16/2011(3) 02/16/2021 Common Stock 30,000 30,000 D
Stock Option (right to buy) $2.67 08/12/2011(4) 07/12/2021 Common Stock 25,000 25,000 D
Stock Option (right to buy) $1.9 01/14/2012(4) 12/14/2021 Common Stock 50,000 50,000 D
Stock Option (right to buy) $3.35(5) 08/10/2012(4) 07/10/2022 Common Stock 355,063 355,063 D
Stock Option (right to buy) $1.31 06/30/2013(4) 05/31/2023 Common Stock 293,110 293,110 D
Stock Option (right to buy) $1.11 03/09/2015 A 75,000 04/09/2015(4) 03/09/2025 Common Stock 75,000 $0.00 75,000 D
Explanation of Responses:
1. Options currently 100% vested.
2. Options vest 33% on date noted and thereafter at 1/24th per month.
3. Half of option vests as to approximately 1,500 shares per month starting 3/16/2011 and ending 12/16/2011. The remaining 15,000 shares will vest provided that certain performance criteria are met.
4. Vests in increments of 1/48th per month, beginning the date shown.
5. The exercise price is the closing price on July 10, 2012, the date the board authorized the grants subject to stockholder approval of the increase in the number of shares available for awards under the incentive plan, which was obtained on September 27, 2012.
Remarks:
/s/ Greg S. Lea, Attorney in Fact for Adrianus (Jos) Donders 03/11/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.